Home>>Peptides>> Amyloid β protein>>Teplow's Amyloid β-Protein (1-42) (scrambled II)

Teplow's Amyloid β-Protein (1-42) (scrambled II)

Catalog No.GA23601

This peptide is a specifically designed negative control in studies with Abeta42. It is "scrambled", which means it contains the same amino acids as Abeta42, but in different order. Referring to studies by Yamin and coworkers, Teplow's Amyloid β-Protein (1-42) does not show a number of phenomena regularly observed with Abeta42 (fibril formation, oligomerization, toxicity to neurons) and furthermore has a relatively flat hydropathy profile, which can be an advantage in several studies, for example in order to avoid unspecific interaction with the cell membrane.

Products are for research use only. Not for human use. We do not sell to patients.

Teplow's Amyloid β-Protein (1-42) (scrambled II) Chemical Structure

Cas No.: 1987844-92-7

Size Price Stock Qty
0.5mg
$459.00
In stock
1mg
$688.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

This peptide is a specifically designed negative control in studies with Abeta42. It is "scrambled", which means it contains the same amino acids as Abeta42, but in different order. Referring to studies by Yamin and coworkers, Teplow's Amyloi

Reviews

Review for Teplow's Amyloid β-Protein (1-42) (scrambled II)

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Teplow's Amyloid β-Protein (1-42) (scrambled II)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.